Bleeker WK - Search Results

1

Clearance of human factor XIa-inhibitor complexes in rats.

Wuillemin WA, Bleeker WK, Agterberg J, Rigter G, ten Cate H, Hack CE. Wuillemin WA, et al. Among authors: bleeker wk. Br J Haematol. 1996 Jun;93(4):950-4. doi: 10.1046/j.1365-2141.1996.d01-1740.x. Br J Haematol. 1996. PMID: 8703832

2

Clearance of human native, proteinase-complexed, and proteolytically inactivated C1-inhibitor in rats.

de Smet BJ, de Boer JP, Agterberg J, Rigter G, Bleeker WK, Hack CE. de Smet BJ, et al. Among authors: bleeker wk. Blood. 1993 Jan 1;81(1):56-61. Blood. 1993. PMID: 8417802 Free article.

3

Inactivation of factor Xia in vivo: studies in chimpanzees and in humans.

Wuillemin WA, Hack CE, Bleeker WK, Biemond BJ, Levi M, ten Cate H. Wuillemin WA, et al. Among authors: bleeker wk. Thromb Haemost. 1996 Oct;76(4):549-55. Thromb Haemost. 1996. PMID: 8902995

4

Activation of clotting factor XI without detectable contact activation in experimental human endotoxemia.

Minnema MC, Pajkrt D, Wuillemin WA, Roem D, Bleeker WK, Levi M, van Deventer SJ, Hack CE, ten Cate H. Minnema MC, et al. Among authors: bleeker wk. Blood. 1998 Nov 1;92(9):3294-301. Blood. 1998. PMID: 9787166 Free article.

5

Intravenous immunoglobulin preparations induce mild activation of neutrophils in vivo via triggering of macrophages--studies in a rat model.

Teeling JL, Bleeker WK, Rigter GM, van Rooijen N, Kuijpers TW, Hack CE. Teeling JL, et al. Among authors: bleeker wk. Br J Haematol. 2001 Mar;112(4):1031-40. doi: 10.1046/j.1365-2141.2001.02674.x. Br J Haematol. 2001. PMID: 11298603 Free article.

6

Effect of polymerization on clearance and degradation of free hemoglobin.

Bleeker WK, Berbers GA, den Boer PJ, Agterberg J, Rigter G, Bakker JC. Bleeker WK, et al. Biomater Artif Cells Immobilization Biotechnol. 1992;20(2-4):747-50. doi: 10.3109/10731199209119713. Biomater Artif Cells Immobilization Biotechnol. 1992. PMID: 1391506

7

Protective effect of antithrombin III in acute experimental pancreatitis in rats.

Bleeker WK, Agterberg J, Rigter G, Hack CE, Gool JV. Bleeker WK, et al. Dig Dis Sci. 1992 Feb;37(2):280-5. doi: 10.1007/BF01308184. Dig Dis Sci. 1992. PMID: 1735347

8

Evaluation of the immunogenicity of polymerized hemoglobin solutions in a rabbit model.

Bleeker WK, Zappeij LM, den Boer PJ, Agterberg JA, Rigter GM, Bakker JC. Bleeker WK, et al. Artif Cells Blood Substit Immobil Biotechnol. 1995;23(4):461-8. doi: 10.3109/10731199509117962. Artif Cells Blood Substit Immobil Biotechnol. 1995. PMID: 7581832

9

Prevention of side effects by hemoglobin solutions; the selection of optimal test models, especially concerning thrombogenicity.

Bakker JC, Bleeker WK, Den Boer PJ, Biessels PT, Agterberg J, Rigter G, Holthuis JC, Mertens K. Bakker JC, et al. Among authors: bleeker wk. Artif Cells Blood Substit Immobil Biotechnol. 1994;22(3):577-85. doi: 10.3109/10731199409117886. Artif Cells Blood Substit Immobil Biotechnol. 1994. PMID: 7994377

10

The potentiation of human C1-inhibitor by dextran sulphate is transient in vivo: studies in a rat model.

Bos IG, van Mierlo GJ, Bleeker WK, Rigter GM, te Velthuis H, Dickneite G, Hack CE. Bos IG, et al. Among authors: bleeker wk. Int Immunopharmacol. 2001 Aug;1(8):1583-95. doi: 10.1016/s1567-5769(01)00073-x. Int Immunopharmacol. 2001. PMID: 11515821

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

80 results

Search Page

Filters